Risk for Clostridioides difficile (C. diff) infection wasn't any greater with vedolizumab (Entyvio) versus anti-tumor necrosis factor (TNF) agents for ulcerative colitis, a researcher reported. In a ...

Clostridium difficile infections elevate the risks for colectomy, mortality and postoperative complications after a colectomy for patients with ulcerative colitis, according to NEJM Journal Watch.

An inflammation of the colon associated with C. difficile — C. difficile colitis — has increased nearly 50 percent from 2001-2005 to 2006-2010, according to a study in the Journal of the American ...

Iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen. A team of Vanderbilt ...

The bacterium Clostridioides difficile, which was formerly named Clostridium difficile and is now commonly known as C. difficile or simply C. diff, is a common microorganism found in the environment.

Newly discovered iron storage 'ferrosomes' inside the bacterium C. diff -- the leading cause of hospital-acquired infections -- are important for infection in an animal model and could offer new ...

The portion of our nervous systems responsible for the 'fight or flight' response can shape the severity of potentially deadly C. difficile infections, according to new research. The portion of our ...

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the ...

The case could represent the first known instance of cat-to-human transmission of recurrent C. diff, though more research is needed to confirm this risk. Reading time 3 minutes A woman’s newly adopted ...

Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a frequent cause of death among hospitalized older adults. Keystone ...

Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause recurring, miserable bouts of diarrhea. Reading time 3 minutes We might soon have a ...

ATLANTA -- Mortality rates from Clostridioides difficile-related infections have fallen steadily since 2016, but the condition continues to take an uneven lethal toll based on sex, demographics, and ...